Survivin degradation by bergenin overcomes pemetrexed resistance

ConclusionsSurvivin overexpression is required for maintaining multiple malignant phenotypes of NSCLC cells. Bergenin exerts a potent antitumor effect on NSCLC via targeting survivin, rendering it a promising agent for the treatment of NSCLC.
Source: Cellular Oncology - Category: Cancer & Oncology Source Type: research